Our Partners

Out-licensing Opportunities

Osmotica continues to actively pursue commercial development partnerships. These co-development agreements provide for the application of Osmotica's technically advanced delivery technologies and extensive drug delivery know-how to our partners' drugs and mutually identified product opportunities.

Supporting Our Partners Products

Osmotica is frequently approached to apply our technologies to resolve drug delivery hurdles to create the optimal product for the market. (Example - Allegra-D® 24 Hour tablet*)

Product Opportunities

Osmotica leverages its drug delivery and development expertise to select product opportunities for co-development or licensed/distribution agreements with third party pharmaceutical companies (Example - Nifedipine Extended-release tablets)

* Allegra-D® is a registered trademark of Sanofi-Aventis U.S. LLC

Contact us to discuss out-licensing opportunities

OVERVIEW OUR BUSINESS OUR HISTORY OUR LOCATIONS DEVELOPMENT FACILITIES OUR MANAGEMENT TEAM OUR BOARD OF DIRECTORS OUR INVESTORS OUR EMPLOYEES WHAT'S NEW OVERVIEW PARTNERING WITH OSMOTICA OUT-LICENSING OPPORTUNITIES IN-LICENSING INTERESTS PROJECT MANAGEMENT OVERVIEW OSMODEX FAMILY OTHER TECHNOLOGIES INTELLECTUAL PROPERTY R&D STRATEGY NEUROLOGY PIPELINE PARTNERED PIPELINE TECHNOLOGY PIPELINE SCIENTIFIC ADVISORY BOARD LICENSED PRODUCTS APPROVED IN U.S. APPROVED IN OTHER COUNTRIES CONTACT US

Version 8 October 6, 2009 | Copyright © 2009 Osmotica Pharmaceutical Corp., All rights reserved. | Terms and Conditions